Radiopaedia Helpers

Headings Valid

warning

Expected headings

H1 Terminology
H1 Clinical applications
H2 Indications
H2 Contraindications
H1 Technique
H2 Physical principles
H2 Device structure
H2 Device function
H2 Image acquisition
H2 Image reconstruction
H2 Post-processing
H2 Technical advances
H2 Protocols
H1 Interpretation
H2 Normal values
H2 Limitations
H2 Pitfalls and artifacts
H1 History and etymology
H1 Practical points
H1 Related articles
H1 See also

"Indications"

Line 9:1 · "Indications" is under the wrong parent heading (found under "").

"Contraindications"

Line 11:1 · "Contraindications" is under the wrong parent heading (found under "").

Commas

suggestion

"As an extracellular contrast agent, gadopentetate dimeglumine can be used in a wide range of MRI applications, including (but not limited to): hepatic imaging, pelvic imaging, cardiac imaging, brain and spine imaging, and musculoskeletal imaging."

Line 10:38 · More than 5 commas in a single sentence might make it more difficult to read.

Oxford Comma

suggestion

"As an extracellular contrast agent, gadopentetate dimeglumine can be used in a wide range of MRI applications, including (but not limited to): hepatic imaging, pelvic imaging, cardiac imaging, brain and spine imaging, and musculoskeletal imaging."

Line 10:188 · Use the Oxford comma in 'imaging, brain and spine'.

There Is

suggestion

"There is an association between the use of gadolinium-based contrast agents (GBCAs) in patients with kidney dysfunction and nephrogenic systemic fibrosis (NSF), a rare, but serious, condition. As a result, the use of three GBCAs; gadopentetate dimeglumine (Magnevist), gadodiamide (Omniscan), and gadoversetamide (OptiMARK) are contraindicated in patients with acute kidney injury or with chronic, severe kidney disease ²."

Line 12:4 · Don't start a sentence with 'There is'.

Parentheses

suggestion

"There is an association between the use of gadolinium-based contrast agents (GBCAs) in patients with kidney dysfunction and nephrogenic systemic fibrosis (NSF), a rare, but serious, condition. As a result, the use of three GBCAs; gadopentetate dimeglumine (Magnevist), gadodiamide (Omniscan), and gadoversetamide (OptiMARK) are contraindicated in patients with acute kidney injury or with chronic, severe kidney disease ²."

Line 12:83 · Use parentheses judiciously. There are at least 3 sets in this paragraph.

Semicolons

suggestion

"There is an association between the use of gadolinium-based contrast agents (GBCAs) in patients with kidney dysfunction and nephrogenic systemic fibrosis (NSF), a rare, but serious, condition. As a result, the use of three GBCAs; gadopentetate dimeglumine (Magnevist), gadodiamide (Omniscan), and gadoversetamide (OptiMARK) are contraindicated in patients with acute kidney injury or with chronic, severe kidney disease ²."

Line 12:246 · Use semicolons judiciously.

Lint: gadopentetate-dimeglumine